These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32064856)

  • 1. [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China].
    Chen W; Wang Q; Li YQ; Yu HL; Xia YY; Zhang ML; Qin Y; Zhang T; Peng ZB; Zhang RC; Yang XK; Yin WW; An ZJ; Wu D; Yin ZD; Li S; Chen QL; Feng LZ; Li ZJ; Feng ZJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):239-244. PubMed ID: 32064856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore.
    Lee VJ; Chiew CJ; Khong WX
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32167146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19.
    Zou H; Shu Y; Feng T
    Infect Dis Poverty; 2020 Jul; 9(1):89. PubMed ID: 32650840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of household quarantine on SARS-Cov-2 infection in mainland China: A mean-field modelling approach.
    Yang JY; Wang GQ; Zhang S
    Math Biosci Eng; 2020 Jun; 17(5):4500-4512. PubMed ID: 33120515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health protection guideline of hotels reconstructed as isolation places for close contacts during COVID-19 outbreak].
    COVID-19 Emergency Response Key Places Protection and Disinfection Technology Team, Chinese Center for Disease Control and Prevention
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Apr; 54(4):351-353. PubMed ID: 32268639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Coronavirus Disease 2019 Community Containment Strategies in Shenzhen, China.
    Zhang XM; Zhou HE; Zhang WW; Dou QL; Li Y; Wei J; Hu R; Liu J; Cheng ASK
    JAMA Netw Open; 2020 Jun; 3(6):e2012934. PubMed ID: 32568401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the UK emulate the South Korean approach to covid-19?
    Majeed A; Seo Y; Heo K; Lee D
    BMJ; 2020 May; 369():m2084. PubMed ID: 32467112
    [No Abstract]   [Full Text] [Related]  

  • 9. Modeling analysis of COVID-19 based on morbidity data in Anhui, China.
    Tian JJ; Wu JB; Bao YT; Weng XY; Shi L; Liu BB; Yu XY; Qi LX; Liu ZR
    Math Biosci Eng; 2020 Mar; 17(4):2842-2852. PubMed ID: 32987501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guide for the prevention and treatment of coronavirus disease 2019].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):473-489. PubMed ID: 32486556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. City lockdown and nationwide intensive community screening are effective in controlling the COVID-19 epidemic: Analysis based on a modified SIR model.
    Peng T; Liu X; Ni H; Cui Z; Du L
    PLoS One; 2020; 15(8):e0238411. PubMed ID: 32857824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As normalcy returns, can China keep COVID-19 at bay?
    Normile D
    Science; 2020 Apr; 368(6486):18-19. PubMed ID: 32241931
    [No Abstract]   [Full Text] [Related]  

  • 13. [The outbreak of COVID-19 in China].
    Buder F; Hitzenbichler F; Ehrenstein B; Salzberger B
    Internist (Berl); 2020 Aug; 61(8):776-781. PubMed ID: 32548651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic curve and reproduction number of COVID-19 in Iran.
    Sahafizadeh E; Sartoli S
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32419024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Covid-19: how to get prepared for Autumn].
    Vineis P; Bisceglia L; Forastiere F; Salmaso S; Scondotto S
    Epidemiol Prev; 2020; 44(4):201-203. PubMed ID: 32921024
    [No Abstract]   [Full Text] [Related]  

  • 16. Community-based prevention and control of COVID-19: Experience from China.
    Zhang Y; Zhao Q; Hu B
    Am J Infect Control; 2020 Jun; 48(6):716-717. PubMed ID: 32291104
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil.
    Garcia LP; Duarte E
    Epidemiol Serv Saude; 2020 Apr; 29(2):e2020222. PubMed ID: 32294756
    [No Abstract]   [Full Text] [Related]  

  • 18. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.
    Phelan AL; Katz R; Gostin LO
    JAMA; 2020 Feb; 323(8):709-710. PubMed ID: 31999307
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of prevention and control interventions and its impact on the epidemic of coronavirus disease 2019 in Chongqing and Guizhou Provinces.
    Dai CX; Yang J; Wang KF
    Math Biosci Eng; 2020 Mar; 17(4):2781-2791. PubMed ID: 32987495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covid-19 - The Law and Limits of Quarantine.
    Parmet WE; Sinha MS
    N Engl J Med; 2020 Apr; 382(15):e28. PubMed ID: 32187460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.